drugset
drugset / Trial / NCT02330003

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

NCT02330003 ↗

Phase 1 Completed 100 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study to evaluate the safety of IL-YANG Inactivated Split Influenza Vaccine (IL-YANG FLU Vaccine Prefilled Syringe INJ.) in comparison with Fluarix Prefilled Syringe (inactivated split influenza vaccine) after single-dose intramuscular administration.

Timeline

Start
2013-05
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject IL-YANG Inactivated Split Influenza Vaccine Vaccine 0.5 ml Intramuscular
Comparator Influenza Virus Vaccine Vaccine 0.5 ml Intramuscular

Indications

No indication recorded.